Medical information siteNo online sale or prescription. The peptides presented are for supervised, experimental use in consultation and do not replace medical advice.
✦ Regenerative Medicine+212 662 100 418
← Catalogue

SS-31

energy & mitochondria protocol
Metabolism & energy · Energy & mitochondria

A peptide that protects the mitochondrion and cellular energy.

iThe essentials in 10 seconds

  • Peptide targeted to mitochondria (the cells' power plants)
  • Protects cardiolipin, essential for proper energy function
  • Reduces oxidative stress and improves energy production
  • Subcutaneous injection, in cycles

IWhat is SS-31?

SS-31The mitochondrial protector

SS-31 (Elamipretide) is a peptide that concentrates in the mitochondria, the cell's power plants. It protects cardiolipin — a lipid essential to the respiratory chain — and reduces oxidative stress. The result: more efficient energy production, particularly in highly demanding tissues (muscle, heart).

Peptide studied in rare mitochondrial and cardiac diseases. Results vary across studies: supervised use, as support, without therapeutic promise.

An innovative approach, an experimental use

The molecules presented on this site are innovative and fall under experimental use. Human data remain limited: a studied mechanism or a preclinical observation is not sufficient to demonstrate a benefit. The regulatory status in Morocco is not established for most of these peptides. Any use is decided within the framework of a medical consultation, with follow-up — never alone, never without an assessment.

IIThe benefits

◆EnergyBoosted mitochondria

Improves cellular energy production by protecting the respiratory chain.

◆Oxidative stressProtected cells

Reduces oxidative stress at the heart of the mitochondrion.

◆Muscle & fatigueExercise capacity

Improves exercise tolerance and reduces muscle fatigue.

◆HeartCardiac tissue

Mitochondrial protection studied in cardiac conditions.

◆CardiolipinThe inner membrane

Protects cardiolipin, essential for energy efficiency.

◆Cellular agingYounger cells

Supports mitochondrial function, a central factor in aging.

IIIRecommendations & how to use

How to useDosage · route · storage
Reconstitution: vial reconstituted with bacteriostatic water (dilution provided during consultation)

Route: subcutaneous injection (abdomen) · Frequency: daily or according to the protocol, in cycles · Storage: refrigerated (2–8 °C).
Often combined with other mitochondrial approaches (NAD+, CoQ10, vitamin C).

Prices on request
DosagePrice
10 mgProvided on request

Prices are not published online: they are provided on request, during a consultation or by telephone.

Supplied as a vial with bacteriostatic water and syringes — reconstituted during the consultation.
Supplied as a vial with bacteriostatic water and syringes — reconstituted during the consultation.

IVThe two protocols

◆Energy protocolFatigue · mitochondria

Goal: support cellular energy in cases of mitochondrial fatigue.

Dose: depending on the form, by injections
Frequency: daily in a cycle of a few weeks
Break between cycles

Monitoring: energy level, tolerance; mitochondrial workup if relevant.

◆Performance protocolEffort · recovery

Goal: improve exercise tolerance and recovery.

Dose: depending on the form, around sessions
Frequency: cycle aligned with the training period
Combine with hydration and rest

SS-31 supports energy: it does not replace rest or recovery.

VProtocol rules

Good habits
  • Regular sleep (mitochondrial repair)
  • Adapted physical activity
  • Hydration and dietary antioxidants
  • Note energy and tolerance
  • Store vials in the refrigerator
To avoid / precautions
  • No self-injection without medical training
  • Do not chain cycles without a break
  • Never mix peptides in the same vial
  • Pregnancy, breastfeeding: medical advice
  • Do not expect an isolated effect without a healthy lifestyle

VIYour journey in 3 steps

Step 1 · Consultation
Assessment & training

Evaluation (energy, fatigue), contraindications, training, protocol provided.

Step 2 · Cycle
Injections & monitoring

Injections according to the protocol, monitoring of energy and tolerance.

Step 3 · Reassessment
Adjustment

Review of energy and recovery, decision on next steps.

VIISide effects & level of evidence

Level of evidenceControlled trialsElamipretide: randomised trials published but primary endpoints missed in the tested indications (PMA, heart failure).
Reported adverse effects
  • Injection-site reaction
  • Headache
  • Dizziness, nausea
  • Fatigue
Contraindications & precautions
  • Pregnancy, breastfeeding
  • Hypersensitivity
  • Severe renal impairment: caution

Non-exhaustive list based on the available literature and known class effects; it replaces neither a product label nor an individual medical assessment.

VIIIPublications & references